Assessment of the Role of EGF +61a/G and EGFR R497K Polymorphism in Patients With Inflammatory Bowel Disease: A Case-Control Study
ARCHIVES OF CLINICAL AND EXPERIMENTAL MEDICINE
doi 10.25000/acem.416704
Full Text
Open PDFAbstract
Available in full text
Date
July 20, 2018
Authors
Publisher
Archives of Clinical and Experimental Medicine